Browsing by Subject "dendritic cell-cytokine-induced killer cell immunotherapy"
Now showing items 1-1 of 1
Predictive significance of T cell subset changes during ex vivo generation of adoptive cellular therapy products for the treatment of advanced non-small cell lung cancer. (Oncology letters, 2019-12)Adoptive T cell immunotherapy with cytokine-induced killer cells (CIKs) has been demonstrated to prolong the survival of patients with advanced non-small cell lung cancer (NSCLC). The aim of the present study was to evaluate ...